Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

3.00
Delayed Data
As of Feb 24
 -0.10 / -3.23%
Today’s Change
2.40
Today|||52-Week Range
4.50
+15.38%
Year-to-Date
No recent news for AcelRx Pharmaceuticals Inc.

Today’s Trading

Previous close3.10
Today’s open3.10
Day’s range3.00 - 3.10
Volume114,653
Average volume (3 months)206,707
Market cap$136.0M
Dividend yield--
Data as of 02/24/2017

Growth & Valuation

Earnings growth (last year)+34.07%
Earnings growth (this year)-61.33%
Earnings growth (next 5 years)+46.60%
Revenue growth (last year)+269.24%
P/E ratioNM
Price/Sales8.89
Price/Book4.10

Competitors

 Today’s
change
Today’s
% change
MRTXMirati Therapeutics ...-0.10-1.75%
DRRXDURECT Corp+0.01+1.02%
KURAKura Oncology Inc-0.15-2.27%
REPHRecro Pharma Inc-0.12-1.62%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 3, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$19.3M
Annual profit (last year)-$24.4M
Net profit margin-126.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Howard B. Rosen
CFO &
Head-Business Development
Timothy E. Morris
Corporate headquarters
Redwood City, California

Forecasts


Search for Jobs